微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 39.93% | -12.15% | -22.67% | 94/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 51.63% | -7.63% | 0.77% | 76/159 | 51.8% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 51.24% | 1.23% | 4.68% | 75/159 | 22.98% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 48.95% | -10.95% | 7.69% | 80/159 | 33.39% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 45.45% | -19.19% | -18.68% | 86/159 | 51.73% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 55.89% | -21.53% | 10.43% | 68/159 | 51.53% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 50.61% | -31.19% | -7.92% | 76/159 | 32.76% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 54.96% | -24.31% | -2.27% | 68/159 | 38.65% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 56.24% | -27.56% | -21.04% | 64/159 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 71.23% | -8.83% | -3.16% | 37/159 | 53.74% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 73.55% | 2% | 1.28% | 36/159 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 72.62% | -12.27% | -6.47% | 38/159 | 21.74% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 77.64% | 2% | -0.62% | 28/159 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 78.13% | -4.16% | -5.61% | 29/159 | 55.21% | 首药控股 | 99.93% | 行业排名> |
| 2021-06-30 | 82.77% | 2% | 1.54% | 19/159 | 47.45% | 艾力斯 | 99.41% | 行业排名> |
| 2020-12-31 | 81.52% | 31.38% | 31.38% | 20/159 | -144.37% | 艾力斯 | 98.7% | 行业排名> |
| 2019-12-31 | 62.05% | 23.55% | 23.55% | 55/159 | -1213.38% | 艾力斯 | 99.4% | 行业排名> |
| 2018-12-31 | 50.22% | 2% | 2% | 71/159 | -205.91% | 首药控股 | 99.94% | 行业排名> |